SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-000275
Filing Date
2018-01-10
Accepted
2018-01-10 07:37:25
Documents
17
Period of Report
2018-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 31423
2 EXHIBIT 99.1 tlgtjpminvestordeck11018.htm EX-99.1 16992
3 tlgtjpminvestordeck11018001.jpg GRAPHIC 65425
4 tlgtjpminvestordeck11018002.jpg GRAPHIC 250187
5 tlgtjpminvestordeck11018003.jpg GRAPHIC 110174
6 tlgtjpminvestordeck11018004.jpg GRAPHIC 165590
7 tlgtjpminvestordeck11018005.jpg GRAPHIC 131733
8 tlgtjpminvestordeck11018006.jpg GRAPHIC 165465
9 tlgtjpminvestordeck11018007.jpg GRAPHIC 109121
10 tlgtjpminvestordeck11018008.jpg GRAPHIC 134195
11 tlgtjpminvestordeck11018009.jpg GRAPHIC 103606
12 tlgtjpminvestordeck11018010.jpg GRAPHIC 121334
13 tlgtjpminvestordeck11018011.jpg GRAPHIC 201891
14 tlgtjpminvestordeck11018012.jpg GRAPHIC 78202
15 tlgtjpminvestordeck11018013.jpg GRAPHIC 120316
16 tlgtjpminvestordeck11018014.jpg GRAPHIC 148142
17 tlgtjpminvestordeck11018015.jpg GRAPHIC 132069
  Complete submission text file 0001628280-18-000275.txt   2814137
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-08568 | Film No.: 18520331
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences